Cargando…
Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study
BACKGROUND: Leflunomide (LEF) has been considered as an alternative treatment for Takayasu arteritis (TA); however, data on its efficacy are still scanty. OBJECTIVE: To investigate the efficacy and safety of LEF versus cyclophosphamide (CYC) for initial-onset TA. METHODS: Initial-onset TA patients w...
Autores principales: | Ying, Sun, Xiaomeng, Cui, Xiaomin, Dai, Jiang, Lin, Peng, Lv, Lili, Ma, Rongyi, Chen, Zongfei, Ji, Huiyong, Chen, Lindi, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268110/ https://www.ncbi.nlm.nih.gov/pubmed/32536986 http://dx.doi.org/10.1177/1759720X20930114 |
Ejemplares similares
-
Effectiveness and safety of methotrexate versus
leflunomide in 12-month treatment for Takayasu arteritis
por: Wu, Chunling, et al.
Publicado: (2020) -
Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu’s arteritis: an observational study
por: Dai, Xiaomin, et al.
Publicado: (2020) -
Involvement of the pulmonary arteries in patients with Takayasu arteritis: a prospective study from a single centre in China
por: Kong, Xiufang, et al.
Publicado: (2020) -
Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis
por: Chen, Rongyi, et al.
Publicado: (2021) -
Serum leptin, a potential predictor of long‐term angiographic progression in Takayasu’s arteritis
por: Ma, Lili, et al.
Publicado: (2019)